In this study, we have identified a secreted 13 kDa lectin from Mtb (Mtb, Mycobacterium tuberculosis; sMTL-13) by homology search of a non-redundant lectin database. Bioinformatic analysis revealed that sMTL-13 belongs to the ricin-type b-trefoil family of proteins containing a Sec-type signal peptide present in Mtb complex species, but not in nontuberculous mycobacteria. Following heterologous expression of sMTL-13 and generation of an mAb (clone 276.B7/IgG1j), we confirmed that this lectin is present in culture filtrate proteins from Mtb H37Rv, but not in non-tuberculous mycobacteria-derived culture filtrate proteins. In addition, sMTL-13 leads to an increased IFN-c production by PBMC from active tuberculosis (ATB) patients. Furthermore, sera from ATB patients displayed high titers of IgG Ab against sMTL-13, a response found to be decreased following successful antituberculosis therapy. Together, our findings reveal a secreted 13 kDa ricin-like lectin from Mtb, which is immunologically recognized during ATB and could serve as a biomarker of disease treatment.
Introduction
Tuberculosis (TB) remains a major public health problem in both developing and industrialized countries [1, 2] . Mycobacterium tuberculosis (Mtb), the etiologic agent of TB, is one of the most successful human pathogens and epidemiological studies estimated that one-third of the world population is infected with the bacterium [1, 2] . Although Mtb remains viable in the majority of the infected subjects, only 5-10% of individuals develop active disease later in life [1, 2] . However, the mechanisms for the breakdown of latency are largely unknown [3] . Evidence suggests that both humoral and cellular immune responses are implicated in host resistance against Mtb and cell-mediated immunity is thought to be the major component for protection [1, [4] [5] [6] [7] . While effective immune responses are critical to control Mtb growth inside macrophages, it has been demonstrated that mycobacteriaassociated factors play an important role in TB immunopathogenesis [8] [9] [10] . Thus, secreted molecules are amongst the possible candidates that influence pathogen-host interactions in vivo.
Secretion of proteins is a critical process for bacterial virulence. Mtb possesses a specialized secretion system to transport virulence factors across their unique cell envelope [11, 12] . Although the study of culture filtrate protein (CFP) preparations from Mtb has revealed a myriad of proteins, there remain several other molecules annotated as having ''unknown function'' [13, 14] . For example, Malen et al. using a proteomic approach, have recently detected 257 secreted proteins in CFP fractions from the laboratory strain Mtb H37Rv [13] . However, no function has yet been ascribed to 23% of those molecules. Polypeptides secreted by mycobacteria may modulate inflammatory processes and could serve as targets for immune protection. For example, the 19 kDa lipoprotein has been shown to induce proinflammatory responses by antigen-presenting cells [15] and ESAT-6, a major immunodominant Mtb antigen utilized in IFN-g-based diagnosis assays, was found to modulate innate immune function [16] . These data suggest that mediators synthesized by the pathogen during infection regulate both protective as well as detrimental responses to the host. Thus, discovery and characterization of Mtb-secreted proteins could be an approach to identify novel therapeutic and diagnosis targets as well as biomarkers of disease.
Lectins are classically defined as a family of proteins with the ability to specifically bind carbohydrate moieties. A number of pathogens have been demonstrated to express such molecules, which are involved in recognition and invasion processes [17, 18] . For example, Pseudomonas aeruginosa produces several membrane-associated lectins that promote attachment to epithelial cells and contribute to its virulence [19] . In addition, bacterial lectins could be released into the extracellular milieu and play an important role during infection as demonstrated by experiments using Bordetella [18] . These data suggest that both membrane-expressed and secreted lectins participate in host-microbial interactions. In the case of Mtb, the heparinbinding hemagglutinin adhesin (HBHA) is one of the most studied cell surface-expressed lectins and it has been shown to be critical for bacterial dissemination in vivo [20] . Moreover, the existence of at least 11 hypothetical lectins from Mtb [21] suggests that these molecules may be an important component of the host-mycobacteria interplay. Consistent with this, active TB (ATB) patients have been found to display increased levels of anti-HBHA Ab during active disease [22, 23] , suggesting that mycobacterial lectins may elicit specific immune responses.
We have utilized a previously generated non-redundant lectin data bank [24] in order to identify lectins from Mtb, a major human pathogen. In the present study, we have demonstrated a secreted 13 kDa ricin-like lectin from Mtb (sMTL-13). sMTL-13 was detected in pleural biopsies from ATB patients and led to an increased IFN-g production by PBMC from patients during active disease. Importantly, ATB patients display high titers of serum IgG against sMTL-13, a response found to be rapidly decreased following successful treatment. These data report a secreted Mtb lectin with antigenic activity in human TB and suggest it may be useful as a biomarker of disease therapy.
Results

In silico analysis of the Rv1419 gene
We have previously generated a non-redundant lectin database for searching lectin domains from Arabidopsis thaliana genome [24] . To further evaluate the presence of such domains in an important human pathogen, Mtb, we have adapted this database and identified a single hypothetical lectin encoded by the Rv1419 gene. Figure 1A shows the bioinformatics characterization of the Rv1419 gene. Its open reading frame (ORF) contains 474 nucleotides and the aa sequence encodes a hypothetical protein of 157 residues containing a signal peptide and a predicted molecular mass of 16.8 kDa. The primary aa sequence analysis of the Rv1419-encoded protein reveals a 33aa residues-signal peptide, with a type I signal cleavage site between Ala33 and Asp34. Analysis of the mature protein predicted a molecular weight mass of 13.6 kDa. Positions 31 and 32 of the precursor protein contain the sequence Ala-x-Ala, a motif commonly found preceding the cleavage site [25] . The Rv1419p contains a carbohydrate-binding B-chain ricin domain and belongs to the ricin-type b-trefoil family of proteins, which is composed of three homologous subdomains as well as the presence of a Q-W pattern [26] . B-chain ricin domains have been demonstrated to bind cell surface glycolipids and glycoproteins bearing b-1,4-linked galactose and mannose moieties [27] . In addition, database searching has shown that the Rv1419 ORF displays 100% identity with its homologue from the clinical strain Mtb CDC1551 (GenBank accession number: AE000516.2) as well as M. bovis BCG (GenBank accession number: AM408590.1) and 78% identity to M. marinum (GenBank accession number: CP000854.1) as well as M. ulcerans (Genbank accession number: CP000325.1) homologous gene (Table 1 ). These data suggest the existence of a previously uncharacterized secreted carbohydrate-binding protein from Mtb and related sequences in other mycobacteria.
To further study possible functions of Rv1419 gene product, we have produced a recombinant protein as described in the Materials and methods section. A DNA fragment of 496 bp was obtained (Fig. 1B) , purified, and cloned into the vector pMOSBlue. Sequencing procedure confirmed that cloning and amplification experiments generated an unaltered Rv1419 sequence (data not shown). The fragment was then inserted in-frame with the start codon present at NdeI cleavage site into the plasmid pET15b enabling full production of Rv1419-gene product using Escherichia coli. Figure 1C shows a typical SDS-PAGE experiment of the obtained recombinant Rv1419p demonstrating a single band with molecular weight of $17 kDa. Additionally, we have confirmed that Rv1419p possesses lectin activity based on classical erythrocyte agglutination assays (Fig. 1D ).
Rv1419p is expressed on CFP fraction from Mtb, but not from non-tuberculous mycobacteria Following bidimensional gel analysis and mass spectrometry of CFP from Mtb H37Rv, Malen et al. have recently detected a spot corresponding to the Rv1419 gene product [13] . To further investigate whether Rv1419p is secreted and/or expressed in other Mtb compartments, we have generated a mAb (clone 276.B7/IgG1Kappa) against this protein. Figure 2A $13 kDa band following incubation with the mAb (Fig. 2B ). In contrast, as previously demonstrated [28] , high levels of the 19 kDa lipoprotein corresponding band from Mtb H37Rv were observed in the studied fractions incubated with an anti-19 kDa lipoprotein mAb (Fig. 2B ). Together, these data suggest that CFP from Mtb H37Rv contains reasonable amounts of Rv1419p; therefore we named this protein secreted Mtb Lectin (sMTL-13). Furthermore, to investigate whether sMTL-13 is expressed during active infection in vivo, we have performed immuno-staining in pleural biopsies from ATB patients. Figure 2C shows positive staining for sMTL-13 in tissue granulomas from ATB patients. In contrast, as expected no staining was observed in biopsies from negative IgG1 isotype control (Fig. 2D ), skin biopsies from M. leprae-infected patients (Fig. 2E ), or in tissue granulomas associated with fungal infection (Fig. 2F and data not shown).
sMTL-13-driven PBMC IFN-c and serum IgG responses from ATB patients
A hallmark of mycobacterial infection is the generation of a strong immune response against secreted antigens. A number of antigens secreted by Mtb have been proposed to function as virulence factors and may influence the clinical outcome of TB [11, 12, 29] . We therefore investigated whether sMTL-13 is recognized by TB patients during active disease. First, we measured recall responses by means of IFN-g production of PBMC following exposure to sMTL-13 in vitro. As demonstrated in Fig. 3A , sMTL-13-stimulated PBMC from active TB patients (n 5 11) display increased production of IFN-g when compared with BCG-vaccinated purified protein derivative (PPD)-negative control subjects (n 5 6). In addition, we have performed ELISA in serum samples from 34 diseased individuals as well as 38 control subjects. As shown in Fig. 3B , recently diagnosed TB patients (either naive of treatment or up to 15 days undergoing early chemotherapy; ATB group) presented high titers of anti-sMTL-13 total IgG Ab. Importantly, anti-sMTL-13 IgG titers rapidly decreased during the first months (1-2) of treatment and reached background levels as compared with those from endemic or nonendemic subjects. Moreover, anti-sMTL-13 IgG Ab titers remained at background levels following successful anti-TB chemotherapy (6 months). Furthermore, receiver operating characteristic (ROC) curves analysis at the optimal cutoff point revealed that antisMTL-13 IgG titers display high specificity (90%) as well as sensitivity (93%) for TB diagnosis (Fig. 3C ). There was no significant difference between the areas for ESAT-6 (AUC 5 0.956 (AUC, area under the curve), CI 95%: 0.865-0.985) and sMTL-13 (AUC 5 0.943, CI 95%: 0.855-0.981). Together, these data suggest that TB patients display adaptive immune responses against sMTL-13 during active disease and anti-sMTL-13 Ab are decreased following therapeutic control of Mtb in vivo.
Discussion
Proteins actively secreted during the in vitro early growth phase of Mtb have been the subject of intensive investigation for their ability to elicit immune responses either in vitro or in vivo [30] [31] [32] [33] [34] . In support of this concept, mice immunized with live but not dead bacilli can induce a protective T-cell response, reinforcing the notion that secreted proteins are among the antigens encountered and presented by the host immune system [35] . In this study, we have identified a novel secreted 13 kDa ricin-like lectin in Mtb, namely sMTL-13. This protein's ORF corresponds to Rv1419, a single-copy gene, as defined in the sequenced Mtb H37Rv genome [36] . In silico analysis of the Rv1419 gene suggests that sMTL-13 is initially synthesized as a 16.8 kDa precursor containing a 33-aa hydrophobic leader sequence (signal peptide). The mature form is predicted to be exported/secreted and has a molecular mass of 13.6 kDa. In line with these observations, Western blot analysis of Mtb CFP preparations revealed that the sMTL-13 is at least as abundant as the 19 kDa lipoprotein, a well-known component of CFP [28] . The presence of a consensus Sec-type signal sequence at the N terminus and its removal from the mature form confirm that sMTL-13 is targeted to the extracellular space by Mtb. This result is consistent with a recent report in which the Rv1419-encoded product was detected in CFP by a proteomic approach [13] . Taken together, these data suggest that this protein appears to be actively secreted. However, it is not clear from this analysis whether the sMTL13 is released directly into the culture medium or expressed as a surface protein otherwise secreted by membrane turnover. Although we have not directly addressed this hypothesis, lower amounts of sMTL-13 were detected in either cell wall or membrane fractions, thus raising the possibility that sMTL-13 is anchored in the mycobacterial cell wall. However, the high content of sMTL-13 in CFP fraction points out that this protein appears to be actively secreted. The availability of full-length genome sequences of some mycobacterial species led us to search for Rv1419 homologies. Analysis of the database revealed that Rv1419 ORF is conserved in other strains of Mtb and M. bovis, indicating that this gene is highly conserved among members of the Mtb complex. In contrast, Rv1419 ORF was not detected in several other disease-inducing mycobacteria such as M. avium, M. leprae, M. abcessus, or M. kansasii. Consistent with these findings, M. avium, M. fortuitum, or M. kansasii CFP did not reveal sMTL-13 corresponding bands in immunodetection experiments. However, as expected, this lectin was found to present in M. bovis BCG CFP (data not shown). Database searches also revealed homology ($78%) between Rv1419 and the predicted ORFs from M. ulcerans and M. marinum, in agreement with Ben Amor et al, who found by Southern blotting Figure 2 . Rv1419-encoded protein is detected in the CFP fraction from Mtb H37Rv. (A) CFP fractions from Mtb (10 or 50 mg), M. avium (50 mg), M. fortuitum (50 mg), or M. kansasii (50 mg) were resolved onto an SDS-PAGE, transferred to a nitrocellulose membrane, and probed with the monoclonal supernatant produced against the rec-Rv1419 protein (276.B7); (B) subcellular preparations from MtbH37Rv were prepared as in (A). As a control, the membrane was stripped and re-probed with the mAb raised against the 19 kD lipoprotein (IT-19; 1:1000 dilution). Data shown are representative of two experiments performed. In situ staining of sMTL-13 in ATB patients. Immunohistochemistry of a representative pleural biopsy from three ATB patients with typical mononuclear inflammatory infiltrate (magnification Â 400) is shown. (C) Anti-sMTL13 mAb-positive staining (insert, magnification Â 1000); (D) negative IgG1 isotype control (insert: magnification Â 1000); (E) negative staining in skin section from a leprosy patient's biopsy using the anti-sMTL-13 mAb (magnification Â 400); (F) percentage of total granuloma-stained area for sMTL-13 in TB pleural biopsies or control groups. Results represent the mean7SEM of measurements from three samples/group (five granulomas/slide). analysis that Rv1419-related gene sequence may be present in species from the non-Mtb complex [37] . However, it remains to be determined whether non-Mtb complex mycobacteria express the Rv1419 homologous protein.
As determined by the bioinformatics studies, sMTL-13 possesses 14 predicted sites for carbohydrate recognition (Fig. 1A) . Consistent with this, recombinant sMTL-13 (rec-sMTL-13) induced agglutination of rabbit erythrocytes in vitro (Fig. 1D) , suggesting that this protein displays lectin activity. Several other lectins from Mtb have been described [38, 39] . To date, one of the most studied Mtb lectin is heparin binding HBHA, which is expressed on the bacterium surface and it has been shown to be important in bacterial dissemination in vivo [20] . These evidences suggest that lectin-host interactions are a potential target to facilitate establishment of infection. For that matter, it has been demonstrated that sera from active TB patients display high titers of IgG against HBHA [22] , suggesting that lectins derived from Mtb could play an important role in in vivo infection.
It has been previously shown that active TB patients display circulating IgG Ab against several Mtb secreted molecules [40, 41] . In the present work, we have shown that active TB patients presented high titers of anti-sMTL-13 IgG, a response that decreased following therapy. In comparison with IgG Ab against the well-known secreted protein ESAT-6, ROC curves analysis at the optimal cutoff point revealed that anti-sMTL-13 IgG titers displayed high specificity (90%) as well as sensitivity (93%) for TB diagnosis. Interestingly, titers of anti-sMTL-13 IgG rapidly decreased within the first 2 months of treatment, suggesting that immune responses against this protein diminish following drug-induced control of Mtb proliferation. We therefore speculate that anti-sMTL-13 IgG titers could be utilized as a Figure 3 . Adaptive immune responses against sMTL-13 during active TB. (A) PBMC from healthy BCG-vaccinated control subjects (PPD-negative, n 5 6) or ATB patients (n 5 11) were exposed to purified sMTL-13 (10 mg/mL) for 48 h. IFN-g production was detected in culture supernatants by cytometric beads array (BD). Ã Statistically significant when comparing the sMTL-13 ATB (active TB) group versus the sMTL-13 PPD-negative group (p 5 0.0238, MannÀWhitney test); (B) sera from either healthy subjects (endemic and non-EC) or TB patients (active pulmonary disease and ongoing therapy) were assayed for specific IgG anti-sMTL-13 by ELISA (see the Materials and methods). Results are expressed as median of individual measurement of optical density. # Statistically significant difference (po0.001, KruskalÀWallis test) between ATB and EC or NEC (non-EC) groups. serum biomarker of treatment efficacy. Although this subject is not directly addressed in the present article, it is possible that serum from non-successful treated TB patients display elevated serum anti-sMTL-13 IgG, as demonstrated for CFP antigens [42] . Whether sMTL-13 is a reliable antigen for diagnosis and/or therapeutic purposes remains to be determined.
In summary, our findings demonstrate the existence of a novel secreted ricin-like lectin from Mtb that is recognized by patients during active TB infection. These observations suggest that sMTL-13-host interaction merits further investigation as a potential biomarker of diagnosis/treatment efficacy as well as immunization target. In this regard, it should be noted that secreted antigens are utilized as diagnostic tests as well as a vaccine candidates in current clinical trials [43, 44] .
Materials and methods
In silico sMTL-13 aa sequence analysis
The ORF annotated as hypothetical proteins, unknown function, or putative were filtered from the whole Mtb genome by using a Perl script [24] . The deduced aa sequence from the entire Rv1419 ORF (sMTL-13 containing the signal peptide) was structurally analyzed using ExPASy (Expert Protein Analysis System) Proteomics Server [45] . The SignalP 3.0 server was utilized to identify potential Sec-type signal peptides and cleavage sites based on several Neural Network methods and Hidden Markov models [46] . In order to compare multiple sequences, CLUSTALW and T-COFFE programs were used [47] . Finally, Blast network server at the NCBI has been utilized to identify sequences similar to sMTL-13 and conserved domains.
Expression and purification of rec-sMTL-13
The protein sMTL-13 containing the signal peptide was expressed as a (His)-tagged protein in E. coli. The gene Rv1419 was subcloned into pET15b expression vector (Novagen, USA) coding for six N-terminally located His-residues allowing the expression of a fusion protein. The Rv1419 PCR fragment representing the entire ORF was generated with specific primers engineered to introduce NdeI e XhoI restriction enzymes sites into the resulting PCR product, using Mtb H37Rv DNA as template: NdeI, sense (5 0 -GGAATTCCA-TATGGGTGAATTACGGTTGG-3 0 ) and XhoI, antisense (5 0 -CCGCTCGAGTCATTACGGCACGCTATCCC-3 0 ). PCR was performed (4 min at 941C, 1 min at 941C, 1 min at 561C, and 1 min at 721C for 36 cycles) and sequence was confirmed by DNA sequencing. E. coli BL21(DE3) was grown at 371C to an A 600 (nm) of 0.6, and the expression was performed in the presence of 1 mM isopropylthiogalactoside. Following 4 h induction, cells were harvested by centrifugation and resuspended in 10 mM Na 2 HPO 4 , 10mM NaH 2 PO 4 , 0.5 M NaCl, and 10 mM of imidazole (lysis buffer). Cells were lysed by sonication three times at 30% of amplitude and centrifuged at 5400 Â g, 41C for 20 min. rec-sMTL-13 was recovered as inclusion bodies and resuspended in lysis buffer containing 8 M urea. rec-sMTL-13 was purified by nickel affinity chromatography (GE Healthcare, Brazil) under denaturing conditions, dialyzed, and resuspended in PBS.
Mycobacterial fractions
Subcellular fractions from Mtb H37Rv were used. Whole cell lysate, CFP, membrane, and cell wall fractions were obtained by strain growth to a late-log phase (day 14) in GAS medium as described elsewhere [14, 48, 49] .
Generation of mAb against sMTL-13 (clone 276.B7) Balb/c mice were i.p. immunized with rec-sMTL-13 (4 Â 20 mg) plus AluGel followed by one (20 mg) i.v. injection with the lectin at weekly intervals. Splenocytes were fused with Ag8XP3653 myeloma cells (kindly provided by Prof. Carlos Zanetti/UFSC) in a 5:1 ratio using PEG 50% as fusogen. Cells were then cultured in RPMI 1640 medium (Invitrogen, Brazil) supplemented with 20% FBS (Hyclone, USA) and hybridomas were selected using 0.1 mM hypoxanthine, 4 Â 10 À4 M aminopterine and 0.016 mM thymidine.
Hybridoma supernatants were screened by ELISA, in which purified rec-sMTL-13 was used as the capture antigen (see Detection of Ab against sMTL-13 by ELISA ). Out of the initial 900 clones screened, 12 positive clones were selected based on production of higher titers of Ab against the lectin. Of these, one clone was subcloned by limited dilution and Ig class and subclass were found to be IgG1k as determined by the SBA Clonotyping System/HRP (Southern Biotech, USA 
Immunohistochemistry
Histological sections from pleural TB patients or control leprosy patients were deparaffinized in xylene, rehydrated in alcohol and water. Quenching of endogenous peroxidase was performed with a 1.5% hydrogen peroxide-methanol solution for 20 min. Sections were incubated with normal goat serum (30 min 371C) and then exposed to monoclonal anti-sMTL-13 supernatant (Clone 276.B7).
Incubations with biotinylated goat anti-mouse Ab with streptavidinÀHRP complex (Vectastain Elite ABC reagent, Vector Laboratories, CA, USA) were performed for 30 min at 371C. Positive reactions was detected with 3,3 0 -diaminobenzidine (Dako Cytomation, CA, USA), followed by Harris's hematoxylin counterstaining. Sections were examined microscopically and images were acquired using a Sight DS-5M-L1 digital camera (Nikon, Melville, NY, USA) connected to an Eclipse 50i light microscope (Nikon).
Quantification of anti-sMTL-13 IgG titers
Maxsorb plates (Nunc, Denmark) were coated with rec-sMTL-13 in carbonate buffer overnight at 41C. Plates were washed with PBS/0.05% Tween-20. Sera from patients and individuals were diluted to 1:20 in PBS-0.05% Tween-20 plus 10% goat serum and incubated for 1 h at 371C. Plates were then washed and incubated with HRP-conjugated anti-human IgG (Sigma, USA) at 1:3000 dilution. A substrate solution containing OPD (0.5 mg/mL) in sodium citrate buffer, pH 5.0, and 0.03% H 2 O 2 was used to develop the colorimetric reaction. Reactions were then stopped with 2 M H 2 SO 4 and the A 492 was measured in an ELISA reader (Spectramax, Molecular Devices).
Recall response assay
Blood from active TB patients (n 5 11) or PPD-negative (n 5 6) healthy BCG-vaccinated subjects were collected and PBMC were obtained through Ficoll gradient as previously described [50] . PBMC (5 Â 10 6 cells/mL) were exposed to purified sMTL-13
(10 mg/mL) for 48 h and IFN-g was measured in culture supernatants by a cytometric bead assay (Bencton, Dickinson and Company, USA) following the manufacturer's instructions.
Statistical analysis
Non-parametric MannÀWhitney test, KruskallÀWallis with Dunn's multiple comparison tests or Friedman test were used to the significance of differences between groups. Values of po0.05 were considered statistically significant. The ROC curve was used for analysis of the accuracy values: area under the ROC curve, sensitivity, and specificity, obtained by using MedCalc Statistical (Version 5.00.020, Brussels, Belgium).
